SMAD3 and chronic kidney disease: Smad signaling is the major pathway of TGF-β1 signaling in renal fibrosis, and Smad3 has been shown to mediate renal fibrosis in various mouse models of chronic kidney diseases (Meng et al., 2015; Chen et al., 2018).